News on haematological malignancies
Drug compound could be next-generation treatment for aggressive form of leukaemia
Researchers have been struggling for years to find a treatment for patients who have a…
Browsing: Haematology
Targeted treatment shrinks deadly paediatric brain tumours
Chemotherapy and radiation are effective cancer treatments because they kill rapidly dividing cells, including tumour…
Cancer has a biological clock and this drug may keep it from ticking
A new drug shows potential to halt cancer cells’ growth by stunting the cells’ biological…
Scientists learn how common virus reactivates after transplantation
A new study in Science challenges long-held theories of why a common virus—cytomegalovirus, or CMV—can reactivate and…
No substantial benefit from transplantation reported for a high-risk leukaemia subtype
Checking for minimal residual disease early in treatment can help some young high-risk leukaemia patients…
New leukaemia drug is more effective and easier to use
A landmark study co-authored by a Loyola Medicine oncologist has found that a newer targeted…
An errant editing enzyme promotes tumour suppressor loss and leukaemia propagation
Writing in the journal Cancer Cell, researchers at University of California San Diego School of Medicine…
Survivors of childhood Hodgkin lymphoma face high long-term risk of solid cancers
New research refines existing evidence that survivors of childhood Hodgkin lymphoma face an elevated risk…
ASH 2018: A first stem cell transplant after CAR T-Cell therapy reduces relapses in ALL
In a new study presented at ASH 2018 in San Diego, patients with ALL who received a…
ASH 2018: Ibrutinib outperforms chemoimmunotherapy in older patients with chronic lymphocytic leukaemia
A new study presented at ASH 2018 shows older patients with chronic lymphocytic leukaemia (CLL) have a…